Rapid reversion of Loeffler's endocarditis by imatinib in early stage clonal hypereosinophilic syndrome

Leukemia and Lymphoma

Volumn 45, Issue 12, 2004, Pages 2503-2507

  Rotoli, Bruno ^a   Catalano, Lucio ^a   Galderisi, Maurizio ^a   Luciano, Luigia ^a   Pollio, Giuditta ^a   Guerriero, Anna ^a   D'Errico, Arcangelo ^a   Mecucci, Cristina ^b   La Starza, Roberta ^b   Frigeri, Ferdinando ^c   Di Francia, Raffaele ^c   Pinto, Antonio ^c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

Eosinophilic leukemia; Hyper eosinophilic syndrome; Imatinib; Loeffler's endocarditis

Indexed keywords

DICOUMAROL; HYBRID PROTEIN; IMATINIB; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN TYROSINE KINASE INHIBITOR; SONOVUE;

ADULT; ARTICLE; CASE REPORT; CELL PROLIFERATION; CHROMOSOME ANALYSIS; CONTRAST ECHOCARDIOGRAPHY; CONTRAST ENHANCEMENT; DOPPLER ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY; EMBOLISM; EOSINOPHILIC LEUKEMIA; FLUORESCENCE IN SITU HYBRIDIZATION; HEART LEFT VENTRICLE; HEART MUSCLE FIBROSIS; HEART MUSCLE INJURY; HEART PAPILLARY MUSCLE; HUMAN; HYPEREOSINOPHILIC SYNDROME; IMAGE ANALYSIS; INTRACARDIAC THROMBOSIS; LOW DRUG DOSE; MALE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; SIDE EFFECT; SIMULATION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYPEREOSINOPHILIC SYNDROME; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MRNA CLEAVAGE AND POLYADENYLATION FACTORS; NEOPLASM STAGING; ONCOGENE PROTEINS, FUSION; PIPERAZINES; PYRIMIDINES; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR ALPHA; TIME FACTORS;

EID: 19944428234     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428190400002293     Document Type: Article

References (23)

1. Löffler, W. (1936) "Endocarditis parietalis fibroplastica mit bluteosinophilie. Ein eigenartiges Krankheitsbild", Schweiz Med. Wochenschr., 66, 817-820.
2. Ommen, S.R., Seward, J.B. and Tajik, A.J. (2000) "Clinical and echocardiographic features of Hypereosinophilic Syndromes", Am. J. Cardiol., 86, 110-113.
3. Schaller, J.L. and Burkland, G.A. (2001) "Rapid and complete control of Idiopathic Hypereosinophilia with Imatinib Mesylate", Medscape Gen. Med., 3, 5-9.
4. Gleich, G.J., Leiferman, K.M., Pardanani, A., Tefferi, A. and Butterfield, J.H. (2002) "Treatment of hypereosinophilic syndrome with imatinib mesilate", Lancet, 359, 1577-1578.
5. Abboud, C., Jankov, A., Felgar, R., Arbini, A., Rosell, K. and Liesveld, J. (2002) "Idiopathic Hypereosinophilic Syndrome: in vivo response to Imatinib Mesilate, and inhibition of eosinophil progenitors in vitro", Exp. Hematol., 30, suppl. 1: abs. 184.
6. Ault, P., Cortes, J., Koller, C., Kaled, E.S. and Kantarjian, H. (2002) "Response of idiopathic hypereosinophilic syndrome to treatment with imatinib mesilate", Leukemia Res., 26, 881-884.
7. Cortes, J., Ault, P., Koller, C., Thomas, D., Ferrajoli, A., Wierda, W., et al. (2003) "Efficacy of imatinib mesilate in the treatment of idiopathic hypereosinophilic syndrome", Blood, 101 4714-4716.
8. Pardanani, A., Ketterling, R.P., Brockman, S.R., Flynn, H.C., Paternoster, S.F., Shearer, B.M., et al. (2003) "CHIC2 deletion, a surrogate for FIP1L1-PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predict response to imatinib mesilate", Blood, 102, 3093-3096.
9. Vandenberghe, P., Wlodarska, I., Michaux, L., Zachée, P., Boogaerts, M., Vanstraelen, D., et al. (2004) "Clinical and molecular features of FIP1L1-PDGFRα (+) chronic eosinophilic leukemias. Leukemia, 18, 734-742.
10. Cools, J., DeAngelo, D.J., Gotlib, J., Stover, E.H., Legare, L.D., Cortes, J., et al. (2003) "A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in Idiopathic Hypereosinophilic Syndrome", N. Engl. J. Med., 348, 1201-1214.
11. Degan, M., Mazzocco, F.T., Di Francia, R., Rossi, F.M., Pinto, A. and Gattei, W. (2000) "Normalizing complementary DNA by quantitative reverse transcriptase-polymerase chain reaction of β2-microglobulin: molecular monitoring of minimal residual disease in acute promyelocytic leukemia", Diagn. Mol. Pathol., 9, 98-109.
12. Fauci, A.S., Harley, J.B., Roberts, W.C., Ferrans, V.J., Gralnick, H.R. and Bjornson, B.H. (1982) "The Idiopathic Hypereosinophilic Sindrome", Ann. Intern. Med., 97, 78-92.
13. Bain, B.J. (1996) "Eosinophilic leukemias and the idiopathic hypereosinophilic syndrome", Br. J. Haematol., 95, 2-9.
14. Fujii, N., Ikeda, K., Takahashi, N., Kojimia, K., Kobayashi, Y., Ashiba, A., et al. (2002) "Multilineage involvement in hypereosinophilic syndrome terminating in granulocytic sarcoma and leukaemic transformation with trisomy 8", Br. J. Haematol., 119 716-719.
15. Catalano, L., Alfinito, F., Selleri, C., Luciano, L., Fazio, S. and Rotoli, B. (1987) "Sindrome ipereosinofila esitata in leucemia acuta promielocitica". In Attualità in Ematologia. Atti del XXXI Congresso della Società Italiana di Ematologia. Monduzzi Editore. Bologna, Italy, pp. 83-85.
16. Bain, B.J. (2000) "Hypereosinophilia", Curr. Opin. Hematol., 7, 21-25.
17. Cabrol, C. (1979) "Chromosomal anomaly in eosinophilic leukemia", N. Engl. J. Med., 301, 439.
18. Malbrain, M.L.N.G., Van den Bergh, H. and Zachée, P. (1996) "Further evidence for the clonal nature of the idiopathic hypereosinophilic syndrome: complete hematological and cytogenetic remission induced by interferon-alpha in a case with a unique chromosomal abnormality", Br. J. Hematol., 92, 176-183.
19. Luciano, L., Catalano, L., Sarrantonio, C., Guerriero, A., Califano, C. and Rotoli, B. (1999) "αIFN-induced hematologic and cytogenetic remission in chronic eosinophilic leukemia with t(1;5 ", Haematologica, 84, 651-653.
20. Pardanani, A., Reeder, T., Porrata, L.F., Li, C.Y., Tazelaar, H.D., Baxter, J., et al. (2003) "Imatinib therapy for hypereosinophilic syndrome and other eosinophilic disorders", Blood 101, 3391-3397.
21. Pitini, V., Arrigo, C., Azzarello, D., La Gattuta, G., Amata, C., Righi, M., et al. (2003) "Serum concentration of cardiac Troponin T in patients with hypereosinophilic syndrome treated with imatinib is predictive of adverse outcome", Blood, 102, 3456-3457.
22. Yuan, Q., Austen, K.F., Friend, D.S., Heidtman, M. and Boyce, J.A. (1997) "Human peripheral blood eosinophils express a functional c-kit receptor for stem cell factor that stimulates very late antigen 4 (VLA-4)-mediated cell adhesion to fibronectin and vascular cell adhesion molecule 1 (VCAM-1)", J. Exp. Med., 186, 313-323.
23. Cross, N.C.P. and Reiter, A. (2002) "Tyrosine Kinase fusion genes in chronic myeloproliferative diseases", Leukemia, 16, 1207-1212.